Colorado’s Drug Price Cap Blocked | Denver News

Colorado’s bold move to cap prescription drug prices—starting with Enbrel, slashing costs from $53K to $31K annually—has hit a legal roadblock. A judge blocked the policy, citing potential conflicts with federal patent law and siding with Amgen, which could win its lawsuit. While the ruling frustrates advocates pushing for affordable meds, the judge suggested alternatives like subsidies or direct negotiations. With Enbrel as the only drug capped so far, the future of Colorado’s drug affordability board hangs in the balance as the state reviews the decision and awaits court outcomes. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/87397f149c2d73cc